CELC Celcuity Inc.
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Celcuity Inc. (CELC) is likely a company operating within the life sciences or biotechnology sector, potentially focused on cellular analysis, diagnostics, or related research tools, given its name. Without specific details on its core business, its competitive position would be contingent on proprietary technology, intellectual property, and its ability to innovate and capture market share within its specialized niche.
- The stock exhibits strong long-term momentum, trading significantly above its 200-day moving average by 43.9%, indicating a robust uptrend.
- CELC is currently trading 9.7% above its 50-day moving average, suggesting positive short-term price action despite recent daily fluctuations.
- The substantial market capitalization of $6.38 billion indicates a company with significant scale or perceived future value, attracting institutional interest.
- The current price of 130.91 represents a considerable appreciation from its 52-week low of 10.50, reflecting strong investor confidence and growth over the past year.
- The absence of a P/E ratio implies the company is not currently profitable, posing a significant risk for investors focused on earnings-based valuations.
- The stock has pulled back 13.3% from its 52-week high, which could signal profit-taking, resistance at higher price levels, or a potential shift in investor sentiment.
- A daily decline of 2.3% indicates recent negative pressure on the stock, which could extend into a short-term downtrend if momentum continues to wane.
- The 'Unknown sector' designation makes it challenging to assess industry-specific risks, competitive landscape, and long-term growth drivers, adding a layer of uncertainty.
CELC has demonstrated robust long-term price appreciation, trading well above both its 50-day and 200-day moving averages, signaling a strong underlying uptrend. However, the stock has experienced a recent pullback of 13.3% from its 52-week high and a daily decline of 2.3%, suggesting some recent profit-taking or negative sentiment. The RSI-14 at 53.8 indicates a neutral technical position, neither overbought nor oversold, implying potential for continued consolidation or a resumption of its prior trend.
AI-generated analysis is for informational purposes only and does not constitute financial advice.